Francisco Ibarra, PharmD, BCCCP

Adjunct Assistant Professor
Biomedical Education

Degrees, Education & Certifications:

PharmD, University of California, San Francisco

BA, Psychology (Minor in Education and Applied Psychology), University of California, Santa Barbara

PGY2 Critical Care Pharmacy Residency, The Johns Hopkins Hospital

PGY1 Pharmacy Residency, Stanford Health Care

Board Certified Critical Care Pharmacist

Advanced Cardiovascular Life Support

Basic Life Support

Pediatric Advanced Life Support

Professional Specialties:

Emergency Medicine, Critical Care, Pharmacology

Most Recent Industry Experience:

Emergency Medicine Clinical Pharmacist, Community Regional Medical Center, Fresno, CA

Professional Affiliations & Service:

Member, California Society of Health-System Pharmacists

Member, American Society of Health-System Pharmacists

Latest Research, Publications, and Presentations:

Ibarra, F., Jr, Loi, K., & Vu, A. W. (2022). Safety and Efficacy of Various Intravenous Insulin Infusion Rates in Patients With and Without Diabetes Presenting With Hypertriglyceridemia. The Annals of pharmacotherapy, 10600280211070102. Advance online publication.

Xiao, S. Q., Ibarra, F., Jr, & Cruz, M. (2021). Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation. The Annals of pharmacotherapy, 10600280211056356. Advance online publication.

Ibarra F., Jr (2021). Review of Prothrombin Complex Concentrates Use in Apixaban and Rivaroxaban Associated Intracranial Hemorrhages. Journal of pharmacy practice, 8971900211015059. Advance online publication.